Utilizza questo identificativo per citare o creare un link a questo documento: http://elea.unisa.it/xmlui/handle/10556/536
Record completo di tutti i metadati
Campo DCValoreLingua
dcterms.contributor.authorD’Auria, David-
dcterms.contributor.authorZito Marinosci, Geremia-
dcterms.contributor.authorDe Benedictis, Giuseppe-
dcterms.contributor.authorPiazza, Ornella-
dc.date.accessioned2013-04-10T11:15:28Z-
dc.date.available2013-04-10T11:15:28Z-
dcterms.date.issued2012-
dcterms.identifier.citationD'Auria D, Zito Marinosci G, De Benedictis G, Piazza O. Vaptans and hyponatremia in critical patients. Translational Medicine @ UniSa 2012;3(1):1-14en_US
dcterms.identifier.issn2239-9747en_US
dcterms.identifier.urihttp://hdl.handle.net/10556/536-
dc.description.abstractHyponatremia is the most frequent fluid and electrolyte disorder in hospitalized patients (20%), particularly in ICU, associated with an increase in morbility and mortality. While hypovolaemic hyponatremia needs to be corrected with the replacement of the lost extracellular fluid by isotonic saline, euvolaemic (SIADH) and hypervolaemic hyponatremia (oedematous states like decompensated heart failure, liver cirrhosis, i.e.) are treated by restriction of fluid intake, loop diuretics and hypertonic saline. A novel approach consists in use of vaptans, non-peptide arginine vasopressin (AVP) receptor antagonists. Vaptans cause “aquaresis”, which results in the correction of plasma osmolality and serum sodium levels, without activation of the renin-angiotensin-aldosterone system or changes in blood pressure and renal function. In this paper we critically reviewed the results of the available randomized controlled critical trials, discussing the effectiveness and safety of vaptans in treating hypervolaemic and euvolaemic hyponatremia in critical patients.en_US
dcterms.format.extentP. 1-14en_US
dc.language.isoenen_US
dcterms.sourceUniSa. Sistema Bibliotecario di Ateneoen_US
dcterms.subjectAVP receptor antagonistsen_US
dcterms.subjectHyponatremiaen_US
dcterms.subjectVaptansen_US
dcterms.subjectVasopressinen_US
dcterms.titleVaptans and hyponatremia in critical patientsen_US
dcterms.typeArticleen_US
È visualizzato nelle collezioni:Translational Medicine @ UniSa. Vol.3 (may.-aug. 2012)

File in questo documento:
Non ci sono file allegati a questo documento


Tutti i documenti archiviati in DSpace sono protetti da copyright. Tutti i diritti riservati.